Literature DB >> 33894713

Creatinine-to-cystatin C ratio as a marker of skeletal muscle mass for predicting postoperative complications in patients undergoing gastric cancer surgery.

Jiaqi Gao1, Huiping Liang2, Yun Qian1, Junhai Pan1, Wei Liu1, Weilin Qi1, Wei Zhou3, Xiaolong Ge4, Xianfa Wang1.   

Abstract

BACKGROUND: Gastric cancer patients usually suffer from skeletal muscle depletion. The serum creatinine/ cystatin C ratio (CCR) is a new, simple tool that could serve as a biomarker of skeletal muscle mass. This study explored the ability of the preoperative CCR to predict postoperative complications in patients with gastric cancer.
METHODS: A total of 309 patients with gastric cancer who were undergoing surgery were enrolled in this study. Univariate analyses were conducted to determine the potential risk factors for postoperative complications, and multivariate analyses were used to determine the independent influencing factors of postoperative complications. A receiver operating characteristic curve was conducted to identify the optimal cutoff value of the CCR. Patients were divided into two groups according to the critical value to investigate the relationship between the CCR and postoperative complications.
RESULTS: Postoperative complications occurred in 87 patients. Multivariate analysis suggested that age, red blood cell level, lymphocyte count, cystatin C, CCR, and N factor were independent risk or protective factors for postoperative complications (P<0.001). The optimal cutoff value of the preoperative CCR was 7.117. Compared with the high preoperative CCR group, patients with a low preoperative CCR were more likely to have both mild complications (P<0.001) and major complications (P<0.001).
CONCLUSIONS: The preoperative CCR can effectively predict postoperative complications in gastric cancer patients after surgery.

Entities:  

Keywords:  Serum creatinine/cystatin C (Scr/CysC); gastric cancer; postoperative complications; skeletal muscle depletion

Year:  2021        PMID: 33894713     DOI: 10.21037/apm-20-2366

Source DB:  PubMed          Journal:  Ann Palliat Med        ISSN: 2224-5820


  2 in total

1.  Changes in Mortality According to Creatinine/Cystatin C Ratio in Chronic Kidney Disease and Non-chronic Kidney Disease Patients.

Authors:  Jeong Ah Hwang; Younghoon Song; Jaeun Shin; Eunjung Cho; Shin Young Ahn; Gang Jee Ko; Young Joo Kwon; Ji Eun Kim
Journal:  Front Med (Lausanne)       Date:  2022-03-02

2.  Serum creatinine/cystatin C ratio as a screening tool for sarcopenia and prognostic indicator for patients with esophageal cancer.

Authors:  Chao Zheng; Ellen Wang; Jiang-Shan Li; Kai Xie; Chao Luo; Qi-Yue Ge; Li-Wen Hu; Yi Shen
Journal:  BMC Geriatr       Date:  2022-03-15       Impact factor: 3.921

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.